New consultation on the security of tobacco products – Open!
EFA, in partnership with ENSP, is planning to reply to the open consultation with the purpose to collect inputs for implementing an EU system traceability...
More research into earlier diagnosis – Our response to H2020 consultation
During the summer, EFA had the chance to provide feedback on the development of the work programme 2018-2020 of Horizon 2020 (the European Union’s Research...
U-BIOPRED's role on patient involvement
The Innovative Medicines Initiative (IMI) has published an interview with Professor Peter Sterk, coordinator of U-BIOPRED, one of the first projects launched...
Vote for myAirCoach to win the EC Innovation Radar Prize
The European Commission has listed the myAirCoach device as one of the high potential innovations in EU-funded research and innovation projects for the...
Our programme at ERS Congress
The 26th International Congress of the European Respiratory Society, the largest meeting in the world in the respiratory field, with more than 20.000 participants...
Call to Croatia and Serbia to reinforce tobacco control
EFA co-signed with others 29 NGOs an open letter to the President and Government of the Republic of Croatia and of Serbia expressing deep concerns regarding...
Join us to stop asthma now! Sign the Malaga-London Declaration
28 European patients associations are joining their forces to reduce the burden of asthma through a call for increased investments in research. The Malaga-London...
Is pollen a pollutant? Our views at the European Aerobiology Symposium
EFA was invited to open the European Symposium on Aerobiology celebrated in Lyon from the 18th-22nd July. The event was organised by the European Aerobiology...
EFA’s research on asthma in adolescence will be presented in Gastein
Our latest survey on adherence to treatment of young patients with asthma will be presented at the European Health Forum Gastein (EHFG), the most influential...
Simplified clinical trials results to inform patients – Our response to the EC consultation
In August we sent our comments to the European Commission open consultation on the summary of results of clinical trials for laypersons.
This consultation...
New treatment to reduce asthma severity – Promising AirPROM study
The University of Leicester has led a ground-breaking study, funded by Novartis Pharmaceuticals, National Institute for Health Research (NIHR) and EU-funded...
AirPROM legacy – Check out the booklet
The AirPROM project ended in May 2016, with a public event organised by EFA at the European Parliament, hosted by MEP David Borrelli. However the work...
75th anniversary of the Finnish Organisation for Respiratory Health - Congratulations!
EFA's Member the Organisation for Respiratory Health in Finland, representing patients, celebrated its’ 75th anniversary in August. The event was celebrated...
Allergy prevention and control campaign in Bulgaria
EFA Member the Association of the Bulgarians suffering from Bronchial Asthma, Allergies and COPD (ABBA) has launched a joint awareness campaign for Allergy...
Severe food allergy campaign in France
EFA’s Member the French Association for the Prevention of Allergies has launched a new campaign to raise awareness about the severity of food allergy....
FENAER organises first respiratory patients congress in Madrid
EFA Member the Spanish Federation of Respiratory Diseases’ Associations (FENAER) is organising the first ever respiratory patients symposium in...
Chronic diseases in Europe: the Commission is urged to act
EFA, the European Chronic Diseases Alliance (ECDA) and other public health organisations have sent an open letter to the European Commission urging them...
The European Commission advances on “may contain” allergen labelling
EFA brought to a European Commission workshop on precautionary labelling the patients perspective to abolish “may contain” mentions. With 17 million...
European Medicines Agency celebrates 10 years of collaboration with patients
Our continuous input into the information, evaluation and safety and development policies of medicines in Europe is an achievement that we celebrate, especially...
EFA President moderates debate on care and research at EAACI Congress
On the 13th of June, EFA President Mikaela Odemyr co-moderated a debate at a high-level policy meeting on the challenges and opportunities the European...